Investigative Ophthalmology & Visual Science Cover Image for Volume 64, Issue 8
June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Choroid-peripheral immune signaling in age-related macular degeneration
Author Affiliations & Notes
  • Joseph B. Lin
    John F. Hardesty, MD Department of Ophthalmology & Visual Sciences, Washington University in St Louis School of Medicine, St Louis, Missouri, United States
  • Footnotes
    Commercial Relationships   Joseph Lin JBL is an inventor on a patent application filed by Washington University in St. Louis., Code P (Patent)
  • Footnotes
    Support  This work was supported by: BrightFocus Foundation; Starr Foundation AMD Research Fund; Jeffrey T. Fort Innovation Fund; Siteman Retina Research Fund; Retina Associates Research Fund; NIH grants R01 EY019287, F30 DK130282, T32 GM07200, and P30 EY02687; and an unrestricted grant from Research to Prevent Blindness to the John F. Hardesty, MD Department of Ophthalmology and Visual Sciences at Washington University School of Medicine in St. Louis.
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 4757. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Joseph B. Lin; Choroid-peripheral immune signaling in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2023;64(8):4757.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Presentation Description : Age-related macular degeneration (AMD) is the leading cause of blindness in industrialized nations featuring lipid-rich deposits underneath the retina and neovascularization of the ocular choroidal vasculature. Although systemic immunity plays a critical role in this pathogenic neovascularization, the molecular signals that recruit immune cells to the eye in AMD remain poorly defined. Herein, we prospectively profiled using single cell RNA sequencing (scRNAseq) the peripheral blood mononuclear cells from 65 individuals including AMD and controls, which we integrated with existing choroid scRNAseq data. We generated a network of 242 interactions between choroidal cell types and circulating immune cells that are dysregulated in AMD which included known AMD-relevant genes such as VEGF receptor 2. We also identified several choroid-peripheral immune system interactions that may offer novel targets for therapy. This study highlights the enormous potential of utilizing multi-tissue human data to identify disease-relevant and therapeutically modifiable targets.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×